Skip to main content
. 2012 Jun 21;12:262. doi: 10.1186/1471-2407-12-262

Figure 3 .

Figure 3

Expression of IGF-1R (A, B) and IGF-2R (C, D) using immunohistochemical analysis in endometrial adenocarcinoma with high differentiation (A) (×400), endometrial adenocarcinoma with low differentiation (B) (×400), endometrial adenocarcinoma with moderate differentiation (C) (×400), and endometrial adenocarcinoma with low differentiation (D) (×200).